These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 21831084)

  • 1. The use of rocuronium and sugammadex in a patient with a history of suxamethonium allergy.
    Messer B; Wilkes J
    Anaesthesia; 2011 Sep; 66(9):844. PubMed ID: 21831084
    [No Abstract]   [Full Text] [Related]  

  • 2. Rocuronium antagonized by sugammadex for series of electroconvulsive therapy (ECT) in a patient with pseudocholinesterase deficiency.
    Batistaki C; Kesidis K; Apostolaki S; Kostopanagiotou G
    J ECT; 2011 Mar; 27(1):e47-8. PubMed ID: 21206368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anesthetic management for electroconvulsive therapy using rocuronium bromide and sugammadex sodium in a patient with suspected malignant syndrome].
    Maeda T; Enomoto T; Kamiyama Y; Inada E
    Masui; 2011 Dec; 60(12):1384-6. PubMed ID: 22256579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The increases in potassium concentrations are greater with succinylcholine than with rocuronium-sugammadex in outpatient surgery: a randomized, multicentre trial.
    Sabo D; Jahr J; Pavlin J; Philip B; Shimode N; Rowe E; Woo T; Soto R
    Can J Anaesth; 2014 May; 61(5):423-32. PubMed ID: 24710957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Does rocuronium displace the position of suxamethonium?].
    Sasakawa T; Iwasaki H
    Masui; 2008 Jul; 57(7):860-8. PubMed ID: 18649641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of recovery times from rocuronium-induced muscle relaxation after reversal with three different doses of sugammadex and succinylcholine during electroconvulsive therapy.
    Kadoi Y; Hoshi H; Nishida A; Saito S
    J Anesth; 2011 Dec; 25(6):855-9. PubMed ID: 21947754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Rapid sequence induction in a patient with Steinert myotonic dystrophy: Interest of the association of high doses of rocuronium and sugammadex].
    Pellegrini L; Mercier MF; Cornese A; Blasco V; Albanèse J
    Ann Fr Anesth Reanim; 2012 Feb; 31(2):155-7. PubMed ID: 22154451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sugammadex-rocuronium dosing.
    Kopman AF
    Anesth Analg; 2007 Sep; 105(3):883-4; author reply 884. PubMed ID: 17717263
    [No Abstract]   [Full Text] [Related]  

  • 9. Rocuronium-sugammadex for electroconvulsive therapy management in neuroleptic malignant syndrome: A case report.
    Casas Reza P; Gestal Vázquez M; Outeiro Rosato Á; López Álvarez S; Diéguez García P
    Rev Esp Anestesiol Reanim; 2017 Feb; 64(2):105-107. PubMed ID: 27424873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of profound neuromuscular block by sugammadex administered three minutes after rocuronium: a comparison with spontaneous recovery from succinylcholine.
    Lee C; Jahr JS; Candiotti KA; Warriner B; Zornow MH; Naguib M
    Anesthesiology; 2009 May; 110(5):1020-5. PubMed ID: 19387176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurarization after sugammadex following a prolonged rocuronium infusion for induced hypothermia.
    Murata T; Kubodera T; Ohbayashi M; Murase K; Adachi YU; Matsuda N
    Can J Anaesth; 2013 May; 60(5):508-9. PubMed ID: 23460187
    [No Abstract]   [Full Text] [Related]  

  • 12. Rocuronium-sugammadex use in electroconvulsive therapy of patients with pseudocholinesterase enzyme deficiency.
    Yuksel E; Sergin D; Tanatti B; Alper I
    J Clin Anesth; 2013 Dec; 25(8):680-1. PubMed ID: 24095888
    [No Abstract]   [Full Text] [Related]  

  • 13. The use of rocuronium in a patient with cystic fibrosis and end-stage lung disease made safe by sugammadex reversal.
    Porter MV; Paleologos MS
    Anaesth Intensive Care; 2011 Mar; 39(2):299-302. PubMed ID: 21485682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rocuronium and sugammadex in myotonic dystrophy.
    Baumgartner P
    Anaesth Intensive Care; 2010 Sep; 38(5):959-60. PubMed ID: 20865895
    [No Abstract]   [Full Text] [Related]  

  • 15. Sugammadex usage in a patient with dermatomyositis.
    Kendigelen P; Tutuncu AC; Ashyralyyeva G; Hamamcioglu EA; Kaya G
    J Clin Anesth; 2015 Aug; 27(5):438-9. PubMed ID: 25910531
    [No Abstract]   [Full Text] [Related]  

  • 16. Repeat dosing of rocuronium after reversal of neuromuscular block by sugammadex.
    Matsuki G; Takahata O; Iwasaki H
    Can J Anaesth; 2011 Aug; 58(8):769-70. PubMed ID: 21614668
    [No Abstract]   [Full Text] [Related]  

  • 17. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.
    de Boer HD; Driessen JJ; Marcus MA; Kerkkamp H; Heeringa M; Klimek M
    Anesthesiology; 2007 Aug; 107(2):239-44. PubMed ID: 17667567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of rocuronium-sugammadex algorithm in suspension direct laryngoscopy].
    El Jaouhari SD; Meziane M; Ahtil R; Bensghir M; Haimeur C
    Pan Afr Med J; 2017; 26():232. PubMed ID: 28690746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First human exposure to Org 25969.
    Nigrovic V; Bhatt SB; Amann A
    Anesthesiology; 2006 Aug; 105(2):427; author reply 427. PubMed ID: 16871080
    [No Abstract]   [Full Text] [Related]  

  • 20. Reversal of rocuronium-induced neuromuscular block with sugammadex and resulting histopathological effects in rat kidneys.
    Bostan H; Kalkan Y; Tomak Y; Tumkaya L; Altuner D; Yılmaz A; Erdivanli B; Bedir R
    Ren Fail; 2011; 33(10):1019-24. PubMed ID: 22013936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.